Combined intake of caffeine and low-dose glucose to reduce exercise-related hypoglycaemia in individuals with type 1 diabetes on ultra-long-acting insulin degludec: A randomized, controlled, double-blind, cross-over trial.

Kühne, Tobias; Wallace, Esmè; Herzig, David; Helleputte, Simon; Scott, Sam; Pickles, Jordan; Melmer, Andreas; Stettler, Christoph (2024). Combined intake of caffeine and low-dose glucose to reduce exercise-related hypoglycaemia in individuals with type 1 diabetes on ultra-long-acting insulin degludec: A randomized, controlled, double-blind, cross-over trial. Diabetes, obesity & metabolism, 26(7), pp. 2645-2651. Wiley 10.1111/dom.15580

[img]
Preview
Text
Diabetes_Obesity_Metabolism_-_2024_-_K_hne_-_Combined_intake_of_caffeine_and_low_dose_glucose_to_reduce_exercise_related.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (673kB) | Preview

AIM

To evaluate whether caffeine combined with a moderate amount of glucose reduces the risk for exercise-related hypoglycaemia compared with glucose alone or control in adult people with type 1 diabetes using ultra-long-acting insulin degludec.

MATERIALS AND METHODS

Sixteen participants conducted three aerobic exercise sessions (maximum 75 min) in a randomized, double-blind, cross-over design. Thirty minutes before exercise, participants ingested a drink containing either 250 mg of caffeine + 10 g of glucose + aspartame (CAF), 10 g of glucose + aspartame (GLU), or aspartame alone (ASP). The primary outcome was time to hypoglycaemia.

RESULTS

There was a significant effect of the condition on time to hypoglycaemia (χ2 = 7.674, p = .0216). Pairwise comparisons revealed an 85.7% risk reduction of hypoglycaemia for CAF compared with ASP (p = .044). No difference was observed between GLU and ASP (p = .104) or between CAF and GLU (p = .77). While CAF increased glucose levels during exercise compared with GLU and ASP (8.3 ± 1.9 mmol/L vs. 7.7 ± 2.2 mmol/L vs. 5.8 ± 1.4 mmol/L; p < .001), peak plasma glucose levels during exercise did not differ between CAF and GLU (9.3 ± 1.4 mmol/L and 9.1 ± 1.6 mmol/L, p = .80), but were higher than in ASP (6.6 ± 1.1 mmol/L; p < .001). The difference in glucose levels between CAF and GLU was largest during the last 15 min of exercise (p = .002). Compared with GLU, CAF lowered perceived exertion (p = .023).

CONCLUSIONS

Pre-exercise caffeine ingestion combined with a low dose of glucose reduced exercise-related hypoglycaemia compared with control while avoiding hyperglycaemia.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition

UniBE Contributor:

Wallace, Esmé Dagmar, Herzig, David, Pickles, Jordan Lee, Melmer, Andreas, Stettler, Christoph

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1463-1326

Publisher:

Wiley

Language:

English

Submitter:

Pubmed Import

Date Deposited:

02 Apr 2024 08:41

Last Modified:

05 Jun 2024 00:14

Publisher DOI:

10.1111/dom.15580

PubMed ID:

38558517

Uncontrolled Keywords:

caffeine clinical trial exercise intervention hypoglycaemia randomized trial

BORIS DOI:

10.48350/195528

URI:

https://boris.unibe.ch/id/eprint/195528

Actions (login required)

Edit item Edit item
Provide Feedback